Hideyuki Tamai

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 10

Top Topics

Diffusion Weighted

Hepatitis C Virus

Radiofrequency Ablation

Top Venues

JGH open : an open access journal of gastroenterology and hepatology

Hepatology research : the official journal of the Japan Society of Hepatology

Hepatitis research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Hideyuki Tamai, Jumpei Okamura
Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid. Viruses 15 (2) (2023)
Hideyuki Tamai, Jumpei Okamura
Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid. Viruses 15 (2) (2023)
Hideyuki Tamai, Jumpei Okamura, Kishio Nanjo
Moderate-carbohydrate diet without caloric or lipid restriction for Japanese adult patients with nonalcoholic fatty liver disease: A prospective cohort study. Hepatology research : the official journal of the Japan Society of Hepatology (2023)
Hideyuki Tamai, Jumpei Okamura
Safety and efficacy of switching to pemafibrate from bezafibrate in patients with chronic liver disease. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Hideyuki Tamai, Jumpei Okamura, Takashi Ohoshi, Hisao Wakasaki
Measurements of Serum Mac-2-Binding Protein Glycosylation Isomer and Shear Wave Velocity in Health Checkups Are Useful in Screening for Non-Alcoholic Steatohepatitis. Healthcare (Basel, Switzerland) 9 (5) (2021)
Hideyuki Tamai, Hiroki Minamiguchi, Yoshiyuki Ida, Naoki Shingaki, Tokuro Muroki, Shuya Maeshima, Ryo Shimizu, Junpei Okamura, Takao Koyama, Taisei Nakao, Tetsuo Sonomura
Combination with portosystemic shunt occlusion and antiviral therapy improves prognosis of decompensated cirrhosis. JGH open : an open access journal of gastroenterology and hepatology 4 (4) (2020)
Yoshiyuki Ida, Hideyuki Tamai, Naoki Shingaki, Ryo Shimizu, Shuya Maeshima, Takao Maekita, Mikitaka Iguchi, Masaki Terada, Masayuki Kitano
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablation. Cancer imaging : the official publication of the International Cancer Imaging Society 20 (1) (2020)
Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, Ryo Shimizu, Shuya Maeshima, Junpei Okamura, Akira Kawashima, Taisei Nakao, Takeshi Hara, Hiroyoshi Matsutani, Izumi Nishikawa, Katsuhiko Higashi
Real-world safety and efficacy of sofosbuvir and ledipasvir for elderly patients. JGH open : an open access journal of gastroenterology and hepatology 2 (6) (2018)
Hideyuki Tamai, Yoshiyuki Ida, Naoki Shingaki, Ryo Shimizu, Kazuhiro Fukatsu, Masahiro Itonaga, Takeichi Yoshida, Yoshimasa Maeda, Kosaku Moribata, Takao Maekita, Mikitaka Iguchi, Jun Kato, Masayuki Kitano
Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir. Hepatitis research and treatment 2017 (2017)
Yasunobu Yamashita, Jun Kato, Kazuki Ueda, Yasushi Nakamura, Yuki Kawaji, Hiroko Abe, Junya Nuta, Takashi Tamura, Masahiro Itonaga, Takeichi Yoshida, Hiroki Maeda, Takao Maekita, Mikitaka Iguchi, Hideyuki Tamai, Masao Ichinose
Contrast-Enhanced Endoscopic Ultrasonography for Pancreatic Tumors. BioMed research international 2015 (2015)
Hideyuki Tamai, Ryo Shimizu, Naoki Shingaki, Yoshiyuki Mori, Shuya Maeshima, Junya Nuta, Yoshimasa Maeda, Kosaku Moribata, Yosuke Muraki, Hisanobu Deguchi, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Jun Kato, Masao Ichinose
Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks. Hepatitis research and treatment 2014 (2014)